drugset / Trial / NCT03120468
Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a pilot study designed to evaluate the safety, tolerability of Topiramate (TPM) + N-Acetyl Cysteine (NAC) in combination versus Topiramate (TPM) + placebo for the treatment of alcohol use disorder (AUD).
Timeline
- Start
- 2017-05-01
- Primary completion
- 2019-06-30
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 600 mg | — |
| Subject | Topiramate | Small molecule | 200 mg | — |